Ependymoblastoma

• CLINICAL_TRIALS trial_result · 2026-02-20
  Clinical Trial Update: An Intermediate Expanded Use Trial of DFMO

  This is an update on an intermediate expanded-use trial of DFMO for neuroblastoma and several embryonal CNS tumors, including medulloblastom…

• CLINICAL_TRIALS trial_result · 2018-07-03
  Clinical Trial Update: Plerixafor After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed High Grade Glioma [Phase 1, Phase 2]

  Phase 1/2 clinical trial assessing plerixafor after radiation therapy and temozolomide in newly diagnosed high-grade glioma has completed wi…

• CLINICAL_TRIALS trial_result · 2015-06-08
  Clinical Trial Update: Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2 [Phase 1]

  Phase I trial evaluating intratumoral GRm13Z40-2 T-cell therapy (genetically modified allogeneic CD8+ T cells expressing IL-13-Zetakine and …